Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

Tag: WHO GMP guidelines

An Introduction to TGA GMP Regulations in Australia

Posted on December 10, 2024 By digi

An Introduction to TGA GMP Regulations in Australia Comprehensive Overview of TGA GMP Regulations in Australia Introduction to TGA GMP Regulations The Therapeutic Goods Administration (TGA) is Australia’s regulatory authority responsible for ensuring the safety, quality, and efficacy of therapeutic goods, including medicines, medical devices, and biologics. To maintain these high standards, the TGA enforces…

Read More “An Introduction to TGA GMP Regulations in Australia” »

TGA GMP Guidelines

COFEPRIS GMP Compliance: Best Practices for Pharmaceutical Manufacturers

Posted on December 10, 2024 By digi

COFEPRIS GMP Compliance: Best Practices for Pharmaceutical Manufacturers COFEPRIS GMP Compliance: Best Practices for Pharmaceutical Manufacturers Introduction to COFEPRIS GMP Compliance In Mexico, the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) is the regulatory authority responsible for overseeing the pharmaceutical industry, ensuring that drugs and other health-related products meet the required safety, efficacy,…

Read More “COFEPRIS GMP Compliance: Best Practices for Pharmaceutical Manufacturers” »

GMP in Latin America (ANVISA, COFEPRIS)

The Role of NMPA GMP in Biopharmaceutical Manufacturing in China

Posted on December 10, 2024 By digi

The Role of NMPA GMP in Biopharmaceutical Manufacturing in China The Role of NMPA GMP in Biopharmaceutical Manufacturing in China Introduction to Biopharmaceutical Manufacturing and NMPA GMP Biopharmaceuticals, including vaccines, monoclonal antibodies, and gene therapies, have revolutionized the healthcare industry. These biologically derived drugs offer new treatments for previously untreatable diseases, but they also present…

Read More “The Role of NMPA GMP in Biopharmaceutical Manufacturing in China” »

NMPA GMP Guidelines

The Role of MHRA GMP in Clinical Trials and IMPs in the UK

Posted on December 10, 2024 By digi

The Role of MHRA GMP in Clinical Trials and IMPs in the UK Understanding the Role of MHRA GMP in Clinical Trials and Investigational Medicinal Products (IMPs) Introduction to MHRA GMP in Clinical Trials Clinical trials are a critical phase in drug development, where investigational medicinal products (IMPs) are tested for safety, efficacy, and optimal…

Read More “The Role of MHRA GMP in Clinical Trials and IMPs in the UK” »

MHRA GMP Guidelines

How Schedule M (Revised) GMP Guidelines Affect Pharmaceutical Operations in India

Posted on December 10, 2024 By digi

How Schedule M (Revised) GMP Guidelines Affect Pharmaceutical Operations in India Impact of Revised Schedule M GMP Guidelines on India’s Pharmaceutical Operations Introduction to Schedule M (Revised) and Its Significance India’s pharmaceutical industry has long been a global leader, supplying affordable and effective medications worldwide. However, ensuring that these products meet international safety and quality…

Read More “How Schedule M (Revised) GMP Guidelines Affect Pharmaceutical Operations in India” »

SCHEDULE - M - Revised

How to Achieve GMP Compliance According to PMDA Guidelines

Posted on December 10, 2024 By digi

How to Achieve GMP Compliance According to PMDA Guidelines How to Achieve GMP Compliance According to PMDA Guidelines Introduction to GMP Compliance and PMDA Guidelines Good Manufacturing Practice (GMP) is a set of regulatory guidelines that ensure pharmaceutical products are produced and controlled to the highest safety and quality standards. In Japan, the Pharmaceutical and…

Read More “How to Achieve GMP Compliance According to PMDA Guidelines” »

PMDA GMP Guidelines

The Role of EMA GMP in Preventing Contamination in Pharmaceutical Manufacturing

Posted on December 9, 2024 By digi

The Role of EMA GMP in Preventing Contamination in Pharmaceutical Manufacturing How EMA GMP Guidelines Safeguard Pharmaceutical Manufacturing from Contamination Introduction to Contamination Prevention in Pharma Contamination prevention is a critical aspect of pharmaceutical manufacturing, as it directly impacts product safety, efficacy, and regulatory compliance. The European Medicines Agency (EMA)’s Good Manufacturing Practices (GMP)) provide…

Read More “The Role of EMA GMP in Preventing Contamination in Pharmaceutical Manufacturing” »

EMA GMP Guidelines

How to Prepare for an ANVISA GMP Inspection in Brazil

Posted on December 9, 2024 By digi

How to Prepare for an ANVISA GMP Inspection in Brazil How to Prepare for an ANVISA GMP Inspection in Brazil Introduction to ANVISA GMP Inspections In Brazil, the National Health Surveillance Agency (ANVISA) is the regulatory authority responsible for ensuring the safety, efficacy, and quality of pharmaceutical products. One of the key aspects of maintaining…

Read More “How to Prepare for an ANVISA GMP Inspection in Brazil” »

GMP in Latin America (ANVISA, COFEPRIS)

How to Achieve Compliance with NMPA GMP Guidelines

Posted on December 9, 2024 By digi

How to Achieve Compliance with NMPA GMP Guidelines Achieving Compliance with NMPA GMP Guidelines for Pharmaceutical Manufacturing Introduction to NMPA GMP Compliance In China, the pharmaceutical industry is tightly regulated to ensure that drugs are produced under safe, consistent, and high-quality conditions. The National Medical Products Administration (NMPA), formerly known as the China Food and…

Read More “How to Achieve Compliance with NMPA GMP Guidelines” »

NMPA GMP Guidelines

MHRA GMP Guidelines for Biopharmaceutical Manufacturing

Posted on December 9, 2024 By digi

MHRA GMP Guidelines for Biopharmaceutical Manufacturing Comprehensive Insights into MHRA GMP Guidelines for Biopharmaceutical Manufacturing Introduction to MHRA GMP in Biopharmaceuticals Biopharmaceutical manufacturing involves the production of complex biologic drugs derived from living organisms. These products, including monoclonal antibodies, vaccines, and gene therapies, demand stringent quality control and regulatory oversight due to their intricate nature…

Read More “MHRA GMP Guidelines for Biopharmaceutical Manufacturing” »

MHRA GMP Guidelines

Posts pagination

Previous 1 … 45 46 47 … 50 Next

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog
Widget Image
  • Never Handle Rejected Goods During Active GMP Production

    Never Handle Rejected Goods During… Read more

WHO GMP guidelines

  • Overview of the WHO Prequalification Program: Scope, Process, and Global Role
  • Role of ICH, WHO, and PIC/S in Setting Global GMP Inspection Benchmarks
  • How to Meet Health Canada GMP Requirements for Pharmaceutical Packaging and Distribution
  • Health Canada GMP Compliance and Its Impact on Global Pharma Manufacturing
  • How FDA GMP Guidelines Shape the Future of Pharmaceutical Manufacturing
  • How Health Canada GMP Regulations Promote Drug Safety and Efficacy
  • Best Practices for Preparing for FDA GMP Inspections in Pharmaceutical Facilities
  • How to Use FDA GMP Compliance to Improve Operational Efficiency
  • How Health Canada GMP Helps with Regulatory Inspections in Canada
  • How FDA GMP Regulations Address Packaging and Labeling Compliance

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme